Figure 3.
(A) Disease-free survival among the entire cohort of CBF AML patients according to KIT mutational status; (B) Relapse risk for the cohort of CBF AML patients according to KIT mutational status.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.